ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

SWOG Releases RFA For Use Of Biorepository

November 12, 2010

Pittsburgh Reprimands Staff For Use of Univ. Resources In Mailing

May 13, 1994

Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.

September 28, 2001

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

In Brief: Bailes Elected President Of ASCO For 1999; Outlines Goals In Remarks To ACCC

March 20, 1998